Structure Therapeutics Files Definitive Proxy Statement
Ticker: GPCR · Form: DEF 14A · Filed: Apr 24, 2025 · CIK: 1888886
| Field | Detail |
|---|---|
| Company | Structure Therapeutics Inc. (GPCR) |
| Form Type | DEF 14A |
| Filed Date | Apr 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Structure Therapeutics DEF 14A filed. Annual meeting June 23. Vote your shares!
AI Summary
Structure Therapeutics Inc. filed its definitive proxy statement on April 24, 2025, for its annual meeting on June 23, 2025. The company, formerly known as ShouTi Inc. until October 19, 2021, is a pharmaceutical preparations company based in South San Francisco, CA. This filing is related to the company's governance and shareholder voting matters.
Why It Matters
This filing outlines the agenda and proposals for Structure Therapeutics' upcoming shareholder meeting, impacting corporate governance and strategic decisions.
Risk Assessment
Risk Level: low — This is a routine proxy filing for an annual shareholder meeting, not indicating new financial risks or significant operational changes.
Key Players & Entities
- Structure Therapeutics Inc. (company) — Registrant
- ShouTi Inc. (company) — Former company name
- 20250424 (date) — Filing date
- 20250623 (date) — Conformed period of report (meeting date)
- 0001888886 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- 981480821 (company) — EIN
- 1231 (date) — Fiscal year end
- 001-41608 (company) — SEC File Number
- 25867799 (company) — Film Number
FAQ
What is the purpose of this DEF 14A filing?
This filing is a definitive proxy statement filed by Structure Therapeutics Inc. for its annual shareholder meeting.
When is the annual shareholder meeting scheduled?
The conformed period of report is June 23, 2025, indicating the date of the annual shareholder meeting.
What was Structure Therapeutics Inc. formerly known as?
Structure Therapeutics Inc. was formerly known as ShouTi Inc., with a name change date of October 19, 2021.
Where is Structure Therapeutics Inc. located?
The company's business address is 611 Gateway Blvd Suite 223, South San Francisco, CA 94080.
Is there a fee required for this filing?
No fee is required for this filing, as indicated by the 'No fee required' checkbox being selected.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 24, 2025 regarding Structure Therapeutics Inc. (GPCR).